Seizure control and pregnancy outcomes in Chinese women with epilepsy: A prospective multicenter cohort study
Epilepsia · 2025
DOI: 10.1111/epi.18294 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Epilepsia, 2025. Verfasst von Nanya Hao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy, Pregnancy Outcome, Pregnancy Complications. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province, The West China Nursing Discipline Development Special Fund Project, Sichuan University, 1.3.5 project for disciplines of excellence and Brain Science project of West China Hospital, Sichuan University.
Abstract (Originalsprache)
Objective
Data on seizure and pregnancy outcomes in Asian women with epilepsy are limited. We used a Chinese pregnancy registry to assess the impact of seizures and antiseizure medications (ASMs) on pregnant women with epilepsy and their children.
Methods
This is an ongoing prospective multicenter study of pregnant women with epilepsy that has been running since 2012. Eligible participants were consecutively enrolled and had multiple follow‐ups up to one year after delivery. We assessed ASM use and seizure frequency during pregnancy to establish potential effects on the mothers and infants and to identify relevant correlations. Descriptive analysis was used to estimate proportions. Logistic regression was used to identify the relevant risk factors and correlations.
Results
Of 1907 potentially eligible pregnancies, we included 1763 in 1483 women with known outcomes from January 2012 to February 2022. There were 1278 completed pregnancies, resulting in 1270 live births. Tonic–clonic seizures occurred in fewer than one‐third of pregnancies in each trimester. Compared with baseline, seizure frequency remained relatively stable throughout approximately two‐thirds of the pregnancies. The majority were on ASM, with levetiracetam (39%), oxcarbazepine (19%), and lamotrigine (17.5%) being the most commonly used. In contrast, only 14.2% of pregnancies were exposed to valproate (VPA). There was a declining trend in treatment adjustments over the course of the pregnancy, with most changes occurring in the first trimester. The incidence of major congenital malformation (MCM) was 4.4%, with cardiogenic and orofacial anomalies being the most common. VPA use ( p < .001), lack of folic acid use ( p = .009), positive family history of MCM ( p = .006), and topiramate (TPM) use ( p = .04) were the most important predictors of MCM. Significance Seizure control remained stable for the majority of women with epilepsy throughout pregnancy. Family history of MCM, VPA use, TPM use, and not taking folic acid were strong predictors of MCM in infants born to women with epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
- Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.
- Department of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Neurology, No. 363 Hospital, Chengdu, China.
- Department of Neurology, Shangjin Hospital, Sichuan University, Chengdu, China.
- Melbourne Brain Centre, Departments of Medicine and Neurology, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Ammar T Abdulaziz, Yujie Chen, Lei Chen, Xiaoting Hao, Jinmei Li, Josemir W Sander, Dong Zhou
Förderung
- Natural Science Foundation of Sichuan Province
- The West China Nursing Discipline Development Special Fund Project, Sichuan University
- 1.3.5 project for disciplines of excellence and Brain Science project of West China Hospital, Sichuan University
- National Key Research and Development Program of China
- 1.3.5 Talent Excellence Development Project - West China Hospital of Sichuan University
- Sichuan Province Science and Technology Support Program
- National Natural Science Foundation of China
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Hao, N., Abdulaziz, A. T., Lu, L., Chen, Y., Li, T., Liu, J., Lin, X., Chen, L., Hao, X., Li, J., Wu, X., O'Brien, T. J., Sander, J. W., & Zhou, D. (2025). Seizure control and pregnancy outcomes in Chinese women with epilepsy: A prospective multicenter cohort study. Epilepsia. https://doi.org/10.1111/epi.18294
Vancouver
Hao N, Abdulaziz AT, Lu L, Chen Y, Li T, Liu J, et al. Seizure control and pregnancy outcomes in Chinese women with epilepsy: A prospective multicenter cohort study. Epilepsia. 2025. doi:10.1111/epi.18294
BibTeX
@article{Hao2025,
author = {Hao, Nanya and Abdulaziz, Ammar T and Lu, Lu and Chen, Yujie and Li, Tao and Liu, Jie and Lin, Xu and Chen, Lei and Hao, Xiaoting and Li, Jinmei and Wu, Xintong and O'Brien, Terence J and Sander, Josemir W and Zhou, Dong},
title = {Seizure control and pregnancy outcomes in Chinese women with epilepsy: A prospective multicenter cohort study},
journal = {Epilepsia},
year = {2025},
doi = {10.1111/epi.18294}
}
EUVIMED